State Of Wyoming Replimune Group, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $18,608 - $27,912	-1,397 Reduced 91.07%	137 $2,000
Q1 2022 May 13, 2022	BUY	$15.24 - $29.75 $8,183 - $15,975	537 Added 53.86%	1,534 $26,000
Q4 2021 Feb 11, 2022	BUY	$25.43 - $34.25 $4,323 - $5,822	170 Added 20.56%	997 $27,000
Q3 2021 Feb 11, 2022	SELL	$28.98 - $39.54 $12,954 - $17,674	-447 Reduced 35.09%	827 $25,000
Q2 2021 Feb 11, 2022	BUY	$28.5 - $39.37 $22,372 - $30,905	785 Added 160.53%	1,274 $49,000
Q1 2021 Feb 08, 2022	BUY	$30.22 - $45.57 $14,777 - $22,283	489 New	489 $15,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.